Additionally, LC3B‐I to II conversion was markedly promoted by treatment with exosomes secreted by oxaliplatin‐resistant CRC cells transfected with si‐NC compared to treatment with PBS, while LC3B‐II accumulation was suppressed when exosomal circATG4B was knocked down. This evidence concerns the gene MAP1LC3B and colorectal carcinoma.